Delirium symptoms are associated with decline in cognitive function between ages 53 and 69 years: Findings from a British birth cohort study by Tsui, A et al.
Alzheimer’s & Dementia 14 (2018) 617-622Featured Article
Delirium symptoms are associated with decline in cognitive function
between ages 53 and 69 years: Findings from a British birth cohort studyAlex Tsui*, Diana Kuh, Marcus Richards, Daniel Davis
MRC Unit for Lifelong Health and Ageing at UCL, London, UKAbstract Introduction: Few population studies have investigated whether longitudinal decline after deliriumThe authors decla
*Corresponding a
7580 1501.
E-mail address: a.
https://doi.org/10.1016
1552-5260/ 2017 Th
(http://creativecommoin mid-to-late life might affect specific cognitive domains.
Methods: Participants from a birth cohort completing assessments of search speed, verbal memory,
and the Addenbrooke’s Cognitive Examination at age 69 were asked about delirium symptoms be-
tween ages 60 and 69 years. Linear regression models estimated associations between delirium symp-
toms and cognitive outcomes.
Results: Period prevalence of delirium between 60 and 69 years was 4% (95% confidence interval
3.2%–4.9%). Self-reported symptoms of delirium over the seventh decade were associated with
worse scores in the Addenbrooke’s Cognitive Examination (21.7 points; 95% confidence interval
23.2, 20.1; P 5 .04). In association with delirium symptoms, verbal memory scores were initially
lower, with subsequent decline in search speed by the age of 69 years. These effects were independent
of other Alzheimer’s risk factors.
Discussion: Delirium symptoms may be common even at relatively younger ages, and their presence
may herald cognitive decline, particularly in search speed, over this time period.
 2017 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Keywords: Delirium; Dementia; Cognitive decline; Life course1. Introduction
Delirium is a neuropsychiatric syndrome characterized by
acute cognitive dysfunction and attentional deficits precipi-
tated by acute illness. Delirium is common, affecting around
25%of older inpatients [1,2], and is associatedwith increased
length of hospital admission, risk of institutionalization, and
mortality [3]. In a range of settings, delirium has been
linkedwith subsequent cognitive decline and incident demen-
tia [4–7]. The precise mechanisms underlying these
relationships are unknown but may be independent of
classical Alzheimer’s pathologies such as amyloid beta,
hyperphosphorylated tau, or APOE ε4 genotype [8–10].re that they have no competing interests.
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ns.org/licenses/by/4.0/).Although delirium clearly has an impact on long-term
cognition, current understanding is incomplete in a number
of ways. First, delirium has mainly been investigated in hos-
pital samples [11–13], and population studies are less
common [14,15]. This is relevant because not all patients
with delirium can be assumed to be admitted to hospital;
those who are may have more severe or prolonged
episodes [16]. Second, there is little knowledge of whether
cognitive function after delirium declines in specific do-
mains or whether the observed associations relate to cogni-
tion more generally. Third, there are few studies with
prospective assessments of cognition, before and after
delirium, which are necessary to quantify prior vulnerability
to delirium and its subsequent effects [5,6,14,17]. None of
these studies are exclusively in populations younger than
age 70 years. It is likely that delirium and dementia have
shared and interacting risk factors, although when these
processes start in the life course is unclear.eimer’s Association. This is an open access article under the CC BY license
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ported delirium symptoms and change in two key domains of
cognition—episodic memory and processing speed—be-
tween ages 53 and 69 years, using data from a British birth
cohort study, accounting for the influences of prior cognitive
function as well as early-life and midlife risk factors for Alz-
heimer’s disease. We addressed three questions: (1) What is
the 10-year period prevalence of reported delirium symp-
toms in a birth cohort aged 69 years? (2) Are delirium symp-
toms subsequently associated with deficits in any particular
cognitive domains? (3) Are reported delirium symptoms
associated with cognition at age 69, and cognitive decline
since midlife independently of other factors known to be
associated with Alzheimer’s risk?2. Methods
The MRC National Survey for Health and Development
(NSHD) is a British birth cohort study, following a sample
of 5362 participants born in March 1946. In 2015, when par-
ticipants were aged 69 years, 2698 individuals living in En-
gland, Scotland, and Wales were invited to have a home visit
by a research nurse as part of the 24th follow-up [18]. The
other 2664 participants had either died (n 5 995), perma-
nently refused participation (n 5 654), moved abroad
(n 5 583), or were lost and untraced (n 5 432). Of the
2698 invited, 2148 (80%) completed a home visit and the
maximum sample for this analysis is 2090 who responded
to a question about delirium symptoms (97%).
2.1. Cognitive outcomes at age 69
Main outcome variables were verbal memory and visual
search speed at age 69. All cognitive assessments were car-
ried out by the research nurse according to the same stan-
dardized protocol as at earlier ages [19]. Verbal memory
was assessed using a 15-item word-learning task, where
each word was presented for 2 seconds. The score represents
the total number of words correctly recalled over three iden-
tical trials (maximum 45). Visual search speed was assessed
by crossing out the letters P and W, randomly embedded
within a grid of other letters, as quickly and accurately as
possible in 1 minute. The score represents the total number
of letters searched (maximum 600). For the first time, partic-
ipants were also administered the Addenbrooke’s Cognitive
Examination (version III) (ACE-III), which gives scores in
five domains: attention & orientation (scored 0–18); verbal
fluency (0–14); memory (0–26); language (0–26); and
visuospatial function (0–16) (total score 100).
2.2. Delirium symptoms
At age 69, participants reported whether they had experi-
enced an episode of delirium in the previous 10 years:
“Please think to a time when you have been unwell, perhaps
while in hospital. Sometimes a person’s memory, thinking,
and concentration can get worse over hours and days dueto an illness, for example, infection, operation, or due to
medications. This is delirium. Since 2006, have you experi-
enced delirium symptoms?”
2.3. Covariates
We used previous scores of verbal memory and visual
search speed at age 53 (in 1999) as a baseline measure pre-
dating any delirium from 2006 [19]. Other covariates were
selected from the data collection at ages 60 to 64 years
[20], based on factors previously demonstrated to be impor-
tant in the primary prevention of Alzheimer’s dementia.
These were as follows: diabetes [21], smoking [22,23],
hypertension [24], body mass index (BMI) [20], educational
attainment [22,25,26], and level of physical exercise [23,27].
At ages 60 to 64 years, diabetes was defined as a diagnosis
of type 1 or 2 diabetes mellitus by a doctor. Hypertension was
defined as a physician-diagnosed hypertension, or regular pre-
scription of an antihypertensive, or systolic blood pressure
greater than 160 mm Hg or diastolic blood pressure greater
than 90 mm Hg taken from two measurements. To assess
BMI, height and weight were measured by standardized pro-
tocols using stadiometers and scales. Smoking status was
defined as current smoker, ex-smoker, or lifelong nonsmoker,
corroborated with reports at earlier ages. Participants were
asked how many times in the last 4 weeks they had taken
part in sports or vigorous activities, classified as inactive (no
episodes), less active (1–4 exercise episodes per month),
and more active (five or more exercise episodes per month).
Educational qualifications by the age of 26 yearswere catego-
rized into no educational qualifications or less than ordinary
“O” level; “O” levels; advanced “A” level and higher.
2.4. Statistical analysis
First, using themaximumsamples, the cognitive test scores
(verbal memory, search speed, ACE-III, and its subdomains)
at age 69 and all covariates were assessed in respect to re-
ported delirium symptoms using chi-squared tests and t-tests
as appropriate. Second, for participants with complete data
for visual search speed and verbalmemory at 53 and 69 years,
we used linear regression to estimate the associations between
delirium symptoms and individual cognitive domain at age
69, adjusting only for sex and the corresponding cognitive
measure at age 53.We thenused all other covariates in amulti-
variable model. We tested for interactions between delirium
and each covariate in the fully adjusted models. Finally, we
tested the associations between delirium symptoms and
ACE-III measures (total scores), to derive a comparable esti-
mate of effect size on a clinically relevant scale. Residuals for
all regression models were checked for heteroscedasticity.
Stata 14.1 (StataCorp, Texas) was used for all analyses.3. Results
Of 2090 participants responding to the delirium question,
83 reported symptoms between ages 60 and 69 years, thus a
Table 2
The relationship between history of delirium symptoms and the
Addenbrooke’s Cognitive Assessment (Version 3) at age 69
Mean ACE-II score
Delirium
symptoms
No delirium
symptoms P value
Total/100 89.5 91.6 ,.01
Attention and orientation/18 16.7 16.7 1.00
Verbal fluency/14 10.5 11 .55
Memory/26 22.5 23.4 .01
Language/26 24.9 25.3 .05
Visuospatial/16 14.9 15.1 ,.01
A. Tsui et al. / Alzheimer’s & Dementia 14 (2018) 617-622 619ten-period period prevalence of 4.0% (95% confidence inter-
val [CI] 3.2%–4.9%). No sex differences were observed
(P 5 .59). Complete ACE-III data were available for 1729
participants (81% of home visits). Participant characteristics
for maximum samples by reported delirium symptoms are
shown in Table 1.
At age 69, the mean search speed was lower for those who
reported a history of delirium symptoms than those reporting
none (mean difference226 letters; P, .01) (Table 1). There
was little difference in verbal memory by reported delirium
symptoms (mean difference21 words; P5 .14). At age 53,
no difference in search speed was found between those with
and without subsequent delirium symptoms (mean differ-
ence 24 letters; P 5 .67). In contrast, mean verbal memory
was lower for those with subsequent delirium symptoms
(mean difference 21.6 words; P 5 .04). No associations
were found between delirium symptoms aged 60 to 69 years
and hypertension, diabetes, smoking status, level of activity,
BMI, and educational attainment (Table 1). Higher levels of
exercise at ages 60 to 64 were associated with faster search
speed and higher memory at 69, whereas greater educational
attainment and female sex were associated with higher ver-
bal memory at 69 (Supplementary Table 1).
Delirium symptoms were associated with lower total
ACE-III scores (89.5 points vs. 91.6 points, P , .01)
(Table 2). When examining subscores in the cognitive do-
mains, delirium symptoms were specifically associated
with worse performance in memory and visuospatial func-
tion (Table 2).Table 1
Patient characteristics of study participants with and without symptoms of
delirium between ages 60 and 69 years
Patient characteristics n
Delirium
symptoms
No delirium
symptoms P value
Visual search speed (letters, SD)
Age 69 2053 237 (76) 263 (74) ,.01
Age 53 1968 280 (76) 284 (73) .67
Verbal memory (words, SD)
Age 69 2018 21 (6) 22 (6) .14
Age 53 1955 23 (7) 25 (6) .04
Hypertension at age 60–64 1875 22% 37% .28
Diabetes by 60–64 1956 15% 11% .27
Smoking status at 60–64 1808 .63
Current 13% 10%
Ex 59% 57%
Never 28% 33%
Level of activity age at 60–64 1923 .39
Inactive 66% 58%
Less active (1–4/week) 11% 13%
More active (.5/week) 23% 29%
Educational attainment by 26 2090 .63
,O levels 37% 40%
O levels 20% 16%
A levels 44% 45%
BMI aged 60–64 years 1826 28.7 (4.5) 27.6 (4.8) .19
Abbreviations: SD, standard deviation; BMI, body mass index.
NOTE. Chi-square P value for categorical variables, t-test for continuous
variables.The estimated association between delirium symptoms
and lower search speed did not attenuate after sequentially
adjusting for sex, prior visual search speed at age 53, and
the full set of covariates (Table 3). In this fully adjusted
model, those reporting delirium symptoms searched 31
fewer letters (95% CI241 to212, P, .01) (Table 3). There
was no association between reported symptoms of delirium
and verbal memory performance at age 69, adjusting for co-
variates using the same multivariable model (P 5 .56)
(Supplementary Table 2). For the ACE-III, delirium symp-
toms were associated with 22.4 points (95% CI 24.1 to
20.7, P 5 .01) after adjusting for search speed at age 53.
This association remained, even after accounting for other
covariates (21.7 points, 95% CI 23.2 to 20.1, P 5 .04)
(Table 3).4. Discussion
In a large representative British population cohort at age
69, the 10-year period prevalence of self-reported delirium
symptoms was 4%. Self-reported symptoms of delirium
were associated with lower search speed at age 69 and faster
decline in this domain since age 53. Similar longitudinal as-
sociations were not seen for verbal memory as measured by a
word list task, although cross-sectional differences were
apparent for the ACE-III memory and visuospatial sub-
scores. Taken together, our findings suggest that these self-
reported symptoms of delirium appear to contribute to
decline in different cognitive domains and across ages
younger than previously described.
The major strength of this study derives from its prospec-
tive nature, allowing for the assessment of the independent
associations between prior cognitive test scores and self-
reported symptoms of delirium on cognitive outcomes.
The main weakness of this study was the reliance on self-
report when defining delirium in the community. Self-
reported delirium may have been limited by recall bias or
inability to recognize delirium from the nurse description.
Delirium recall, at least in hospital samples, will be less reli-
able not only in those with amnestic symptoms as part of
their delirium but also in those with more perceptual distur-
bance and indeed those with more severe delirium [28].
Nonetheless, in the absence of an established instrument to
identify delirium in community samples, it would appear
that positive responses to the questionnaire as answered in
Table 3
Differences in visual search speed, verbal memory, and ACE-III at 69, by history of delirium symptoms at ages 60 to 69
Cognitive assessment
Adjusted for sex 1 Adjusted for prior cognition* 1 Adjusted for all covariatesy
n b 95% CI P value b 95% CI P value b 95% CI P value
Visual Search 1523 232 (253, 210) ,.01 233 (251, 214) ,.01 231 (249, 212) ,.01
Verbal Memory 1505 20.9 (22.6, 0.8) .30 20.6 (21.9, 0.7) .38 20.4 (21.6, 0.9) .56
ACE-III 1323 22.4 (24.2, 20.7) .01 22.4 (24.1, 20.7) .01 21.7 (23.2, 20.1) .04
Abbreviations: ACE-III, Addenbrooke’s Cognitive Examination (3rd version), total score out of 100; CI, confidence interval; BMI, body mass index.
NOTE. Visual search 5 letters searched; verbal memory 5 words recalled.
*ACE-III adjusted for search speed at 53.
yHypertension, diabetes, BMI, smoking status, physical activity at ages 60 to 64, education by age 26.
A. Tsui et al. / Alzheimer’s & Dementia 14 (2018) 617-622620our study remain informative in respect of the association
between delirium symptoms and worsening cognition.
Another notable limitation is that delirium symptoms were
recalled over between 60 and 69 years though cognition
was assessed between ages 53 and 69 years; this discrepancy
means that cognitive decline may have taken place in the
7 years after the first cognitive assessment, before any
self-reported symptoms of delirium. This is less likely
because we have shown that the rate of cognitive decline
was faster in the latter period [29]. In common with other
cohort studies, our findings may be subject to residual
confounding and may be specific to the population and era
under study.
The influence of delirium on later life cognitive
impairment had been reported in older adults [4–6,14].
Our study is the first to describe and characterize the
associations between self-reported symptoms of delirium
in the community and later life cognition at relatively
younger ages of 60 to 69 years, though there have beenmajor
studies in younger perioperative [7] and critical care [30]
cohorts. In addition, although studies had reported
associations between delirium and global cognition scores
such as the information-memory-concentration subtest of
the Blessed Dementia Rating Scale [4] and the Mini–Mental
State Examination [5], our study has some domain-specific
findings.
Domain-specific relationships between self-reported
symptoms of delirium and cognition appear to vary over
the life course. Verbal memory scores were already lower
at baseline in those reporting delirium symptoms later in
life, while decline in visual search speed only appeared after
the self-reported symptoms of delirium. At age 69, the ACE-
III scores indicated particular deficits in episodic memory
(slightly broader in scope than our longitudinal word-
learning verbal memory task) and visuospatial functions. In-
sofar as the relationship between delirium and dementia is
bidirectional, lower verbal memory at baseline may suggest
an increased susceptibility to delirium episodes during acute
illness, while declining search speed and visuospatial func-
tions are perhaps adversely affected by processes related to
delirium. Whether particular structural or functional neural
networks are particularly vulnerable to the development
and recovery of delirium is unclear. However, demonstratingcognitive decline after delirium symptoms, after accounting
for Alzheimer’s risk factors, strengthens the emerging idea
that delirium affects cognition via processes independent
of classical dementia mechanisms [10].
Overall, this analysis suggests that episodes of self-
reported symptoms of delirium, as early as in the seventh
decade, are associated with greater decline in processing
speed and may differentially affect other cognitive domains.
These relationships require further replication in other sam-
ples, both observational and experimental. Our findings
highlight the importance for clinicians to assess cognitive
function in patients who are at highest risk of delirium and
subsequently preventing and managing delirium to mini-
mize adverse cognitive sequelae in later life.Acknowledgments
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1. Systematic review: We identified studies in the liter-
ature through an existing systematic review on
delirium epidemiology. We updated the search strat-
egy and found one further publication.
2. Interpretation: Within a British birth cohort study, we
report associations between midlife self-reported
delirium symptoms and faster visual search speed
decline, independent of other known risk factors for
Alzheimer’s disease. Cross-sectional differences
were also apparent for the ACE-III memory and vi-
suospatial subscores. Our results suggest that
delirium symptoms contribute to decline in different
cognitive domains, across ages younger than previ-
ously described and independently of classical Alz-
heimer’s disease mechanisms.
3. Future directions: Future observational and interven-
tional studies should further explore the domain
specificity of cognitive deficits after delirium. This
might include structural and functional imaging
studies in the context of longitudinal follow-up.
References
[1] Siddiqi N, House AO, Holmes JD. Occurrence and outcome of
delirium in medical in-patients: a systematic literature review. Age
Ageing 2006;35:350–64.
[2] Leslie DL, Marcantonio ER, Zhang Y, Leo-Summers L, Inouye SK.
One-year health care costs associated with delirium in the elderly
population. Arch Intern Med 2008;168:27–32.
[3] Witlox J, Eurelings LS, de Jonghe DF, Kalisvaart KJ, Eikelenboom P,
van Gool WA. Delirium in elderly patients and the risk of
postdischarge mortality, institutionalization, and dementia: a
meta-analysis. JAMA 2010;304:443–51.
[4] Fong TG, Jones RN, Shi P, Marcantonio ER, Yap L, Rudolph JL, et al.
Delirium accelerates cognitive decline in Alzheimer’s disease.
Neurology 2009;72:1570–5.
[5] Davis DH, Muniz Terrera G, Keage H, Rahkonen T, Oinas M,
Matthews FE, et al. Delirium is a strong risk factor for dementia in
the oldest-old: a population-based cohort study. Brain 2012;
135:2809–16.
[6] Gross AL, Jones RN, Habtemariam DA, Fong TG, Tommet D,
Quach L, et al. Delirium and long-term cognitive trajectory among
persons with dementia. Arch Intern Med 2012;172:1324–31.[7] Saczynski JS, Marcantonio ER, Quach L, Fong TG, Gross A,
Inouye SA, et al. Cognitive Trajectories after Postoperative Delirium.
N Engl J Med 2012;367:30–9.
[8] Vasunilashorn SM, Ngo L, Kosar CM, Fong TG, Jones RN, Inouye SK,
et al. Does Apolipoprotein E genotype increase risk of postoperative
delirium? Am J Geriatr Psychiatry 2015;23:1029–37.
[9] Witlox J, Kalisvaart KJ, de Jonghe JF, Verwey NA, van Stijn MF,
Houdijk AP, et al. Cerebrospinal fluid beta-amyloid and tau are not
associated with risk of delirium: a prospective cohort study in older
adults with hip fracture. J Am Geriatr Soc 2011;59:1260–7.
[10] Davis DH, Muniz-Terrera G, Keage HA, Stephan BC, Fleming J,
Ince PG, et al. Association of delirium with cognitive decline in late
life: A neuropathologic study of 3 population-based cohort studies.
JAMA Psychiatry 2017;74:244–51.
[11] Eide LS, Ranhoff AH, Fridlund B, Haaverstad R, Hufthammer KO,
Kuiper KK, et al. Delirium as a predictor of physical and cognitive
function in individuals aged 80 and older after transcatheter aortic
valve implantation or surgical aortic valve replacement. J Am Geriatr
Soc 2016;64:1178–86.
[12] Ely EW, Shintani A, Truman B, Speroff T, Gordon SM Jr, Harrell FE,
et al. Delirium as a predictor of mortality in mechanically
ventilated patients in the intensive care unit. JAMA 2004;
291:1753–62.
[13] KrogsethM,Watne LO, JulieboV, Skovlund E, Engedal K, Frihagen F,
et al. Delirium is a risk factor for further cognitive decline in
cognitively impaired hip fracture patients. Arch Gerontol Geriatr
2016;64:38–44.
[14] Davis D, Barnes L, Stephan B,MacLullich A,Meagher D, Copeland J,
et al. The descriptive epidemiology of delirium symptoms in a large
population-based cohort study: results from the Medical Research
Council Cognitive Function and Ageing Study (MRC CFAS). BMC
Geriatr 2014;14:87.
[15] de Lange E, Verhaak PF, van der Meer K. Prevalence, presentation and
prognosis of delirium in older people in the population, at home and in
long term care: a review. Int J Geriatr Psychiatry 2013;28:127–34.
[16] Davis DH, Kreisel SH, Muniz Terrera G, Hall AJ, Morandi A,
Boustani M, et al. The epidemiology of delirium: challenges and
opportunities for population studies. Am J Geriatr Psychiatry 2013;
21:1173–89.
[17] Mathews SB, Arnold SE, Epperson CN. Hospitalization and cognitive
decline: Can the nature of the relationship be deciphered? Am JGeriatr
Psychiatry 2014;22:465–80.
[18] Kuh D, Wong A, Shah I, Moore A, Popham M, Curran P, et al. The
MRC National Survey of Health and Development reaches age 70:
maintaining participation at older ages in a birth cohort study. Eur J
Epidemiol 2016;31:1135–47.
[19] Richards M, Shipley B, Fuhrer R, Wadsworth ME. Cognitive ability in
childhood and cognitive decline in mid-life: longitudinal birth cohort
study. BMJ 2004;328:552.
[20] Albanese E, Hardy R, Wills A, Kuh D, Guralnik J, Richards M. No
association between gain in body mass index across the life course
and midlife cognitive function and cognitive reserve–the 1946 British
Birth Cohort study. Alzheimers Dement 2012;8:470–82.
[21] Vagelatos NT, Eslick GD. Type 2 diabetes as a risk factor
for Alzheimer’s disease: the confounders, interactions, and
neuropathology associated with this relationship. Epidemiol Rev
2013;35:152–60.
[22] Richards M, Jarvis MJ, Thompson N, Wadsworth ME. Cigarette
smoking and cognitive decline in midlife: evidence from a prospective
birth cohort study. Am J Public Health 2003;93:994–8.
[23] Cadar D, Pikhart H, Mishra G, Stephen A, Kuh D, Richards M, et al.
The role of lifestyle behaviors on 20-year cognitive decline. J Aging
Res 2012;2012:304014.
[24] Snyder HM, Corriveau RA, Craft S, Faber JE, Greenberg SM,
Knopman D, et al. Vascular contributions to cognitive impairment
and dementia including Alzheimer’s disease. Alzheimers Dement
2015;11:710–7.
A. Tsui et al. / Alzheimer’s & Dementia 14 (2018) 617-622622[25] Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C, et al. Potential
for primary prevention of Alzheimer’s disease: an analysis of
population-based data. Lancet Neurol 2014;13:788–94.
[26] Hatch SL, Feinstein L, Link BG, Wadsworth ME, Richards M. The
continuing benefits of education: adult education andmidlife cognitive
ability in the British 1946 birth cohort. J Gerontol B Psychol Sci Soc
Sci 2007;62:S404–14.
[27] Richards M, Hardy R, Wadsworth ME. Does active leisure protect
cognition? Evidence from a national birth cohort. Soc Sci Med
2003;56:785–92.[28] Breitbart W, Gibson C, Tremblay A. The delirium experience:
delirium recall and delirium-related distress in hospitalized
patients with cancer, their spouses/caregivers, and their nurses.
Psychosomatics 2002;43:183–94.
[29] Davis D, Bendayan R, Muniz Terrera G, Hardy R, Richards M, et al.
Decline in search speed and verbal memory over 26 years of midlife
in a British birth cohort. Neuroepidemiology 2017;49:121–8.
[30] Pandharipande P, Girard TD, Jackson JC, Morandi A, Thompson JL,
Pun BT, et al. Long-term cognitive impairment after critical illness.
N Engl J Med 2013;370:185–6.
